Search research articles
Contact Us
Filters
Showing results (21-30 of 103) with videos related to
Page
of 11
Sort By:
Pigment Cell & Melanoma Research
|
February 26, 2019
A dual pathway inhibition strategy using BKM120 combined with vemurafenib is poorly tolerated in BRAF V600<sup>E/K</sup> mutant advanced melanoma
Alain Patrick Algazi, Julia Rotow, Christian Posch, et al.
Cancers
|
July 14, 2023
Pulsed Electric Fields in Oncology: A Snapshot of Current Clinical Practices and Research Directions from the 4th World Congress of Electroporation
Luca G Campana, Adil Daud, Francesco Lancellotti, et al.
Melanoma Research
|
August 22, 2022
Melanoma risk during immunomodulating treatment
Yixuan James Zheng, Wilson Ho, Martina Sanlorenzo, et al.
Expert Opinion on Biological Therapy
|
June 15, 2012
Management of pegylated interferon alpha toxicity in adjuvant therapy of melanoma
Adil Daud, Christopher Soon, Reinhard Dummer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 26, 2009
Clinical and biological effects of valproic acid as a histone deacetylase inhibitor on tumor and surrogate tissues: phase I/II trial of valproic acid and epirubicin/FEC
Pamela Munster, Douglas Marchion, Elona Bicaku, et al.
Oncogene
|
October 9, 2002
Roles of activated Src and Stat3 signaling in melanoma tumor cell growth
Guilian Niu, Tammy Bowman, Mei Huang, et al.
Science Immunology
|
October 3, 2020
Regulatory T cell control of systemic immunity and immunotherapy response in liver metastasis
James C Lee, Sadaf Mehdizadeh, Jennifer Smith, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 24, 2017
Phase II randomised discontinuation trial of cabozantinib in patients with advanced solid tumours
Patrick Schöffski, Michael Gordon, David C Smith, et al.
Cancers
|
April 13, 2024
Targeted DNA Sequencing of Cutaneous Melanoma Identifies Prognostic and Predictive Alterations
Alexandra M Haugh, Robert C Osorio, Rony A Francois, et al.
JAMA Dermatology
|
July 30, 2015
Pembrolizumab Cutaneous Adverse Events and Their Association With Disease Progression
Martina Sanlorenzo, Igor Vujic, Adil Daud, et al.
Page
of 11
Search research articles
Search
Showing results (21-30 of 103) with videos related to
Sort By:
Page
of 11
Pigment Cell & Melanoma Research
|
February 26, 2019
A dual pathway inhibition strategy using BKM120 combined with vemurafenib is poorly tolerated in BRAF V600<sup>E/K</sup> mutant advanced melanoma
Alain Patrick Algazi, Julia Rotow, Christian Posch, et al.
Cancers
|
July 14, 2023
Pulsed Electric Fields in Oncology: A Snapshot of Current Clinical Practices and Research Directions from the 4th World Congress of Electroporation
Luca G Campana, Adil Daud, Francesco Lancellotti, et al.
Melanoma Research
|
August 22, 2022
Melanoma risk during immunomodulating treatment
Yixuan James Zheng, Wilson Ho, Martina Sanlorenzo, et al.
Expert Opinion on Biological Therapy
|
June 15, 2012
Management of pegylated interferon alpha toxicity in adjuvant therapy of melanoma
Adil Daud, Christopher Soon, Reinhard Dummer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 26, 2009
Clinical and biological effects of valproic acid as a histone deacetylase inhibitor on tumor and surrogate tissues: phase I/II trial of valproic acid and epirubicin/FEC
Pamela Munster, Douglas Marchion, Elona Bicaku, et al.
Oncogene
|
October 9, 2002
Roles of activated Src and Stat3 signaling in melanoma tumor cell growth
Guilian Niu, Tammy Bowman, Mei Huang, et al.
Science Immunology
|
October 3, 2020
Regulatory T cell control of systemic immunity and immunotherapy response in liver metastasis
James C Lee, Sadaf Mehdizadeh, Jennifer Smith, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 24, 2017
Phase II randomised discontinuation trial of cabozantinib in patients with advanced solid tumours
Patrick Schöffski, Michael Gordon, David C Smith, et al.
Cancers
|
April 13, 2024
Targeted DNA Sequencing of Cutaneous Melanoma Identifies Prognostic and Predictive Alterations
Alexandra M Haugh, Robert C Osorio, Rony A Francois, et al.
JAMA Dermatology
|
July 30, 2015
Pembrolizumab Cutaneous Adverse Events and Their Association With Disease Progression
Martina Sanlorenzo, Igor Vujic, Adil Daud, et al.
Page
of 11